This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Aetiology

Authoring team

ADEM is predominately considered a post-infectious disease of the CNS. An identifiable infection or immunization has been reported in 50% to 85% of cases (1)

ADEM often follows an upper respiratory or gastrointestinal viral infection, viral exanthems (measles, rubella, chickenpox, etc.) or immunisation with viral vaccines - live or killed; influenza, rabies. ADEM is seen in adults and children approximately 8 to 21 days following immunization. The rabies vaccine is the most commonly reported vaccine associated with ADEM.

The frequency of ADEM occurring after vaccination has decreased in recent years, likely related to different methodologies in vaccine production (2)

Reference

  1. Paolilo RB, Deiva K, Neuteboom R, Rostásy K, Lim M. Acute Disseminated Encephalomyelitis: Current Perspectives. Children (Basel). 2020 Nov 03;7(11)
  2. Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014 Mar;13(3):215-24.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.